Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03156270 |
Recruitment Status :
Completed
First Posted : May 17, 2017
Results First Posted : June 16, 2021
Last Update Posted : June 16, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Nasal Obstruction | Device: Vivaer Stylus | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Prospective, Non-Randomized Study to Evaluate Treatment Outcome of Nasal Airway Obstruction Using the Aerin Medical Vivaer™ Stylus |
Actual Study Start Date : | September 19, 2017 |
Actual Primary Completion Date : | July 12, 2019 |
Actual Study Completion Date : | August 6, 2019 |
Arm | Intervention/treatment |
---|---|
Experimental: Vivaer Stylus Treatment
Thermal treatment of the submucosal tissue including cartilage in the internal nasal valve area
|
Device: Vivaer Stylus
Stylus used to deliver low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area
Other Name: Aerin Medical Stylus |
- Change in NOSE Score [ Time Frame: Baseline, 90 days ]
Mean change in Nasal Obstruction Symptom Evaluation (NOSE) score from baseline to 90 days post-study procedure. Improvement (90 day score - baseline score) is signified by a negative value.
The Nasal Obstruction Symptom Evaluation (NOSE) scale is a validated disease-specific health status outcomes instrument, used to assess severity of nasal obstruction symptoms. Score ranges from 0 to 100. Higher scores indicate increased symptoms/symptom severity.
- Change in VAS of Nasal Obstruction [ Time Frame: Baseline, 90 days ]
Change in visual-analog scale (VAS) of nasal obstruction severity as perceived by the subject from baseline to 90 days post-study procedure. Improvement (90-day score - baseline score) is signified by a negative value.
The visual-analog scale (VAS) of nasal obstruction is presented to the subject as a 10cm line anchored on each end by verbal descriptors: 0 = No Obstruction and 10 = Completely Obstructed. The subject is asked to place a vertical mark on the line to show the level of nasal obstruction they feel. The distance between 0 and the vertical mark made by the subject is measured and the results is expressed in centimeters. Higher scores indicate more severe obstruction.
- Change in Peak Nasal Inspiratory Flow [ Time Frame: Baseline, 90 days ]Peak inspiratory flow measurements of nasal physical resistance

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Complaints of nasal obstruction for at least 1 year
- Failed maximum medical therapy (4-6 weeks of steroids)
- Nasal Obstruction Symptom Evaluation (NOSE) score of ≥ 60 at Baseline
-
Nasal valve is a primary or significant contributor to the subject's nasal obstruction as determined by the study investigator (based on clinical presentation, physical examination, nasal endoscopy, etc.) and the subject has a positive response to any of the following temporary measures (based on patient history or during office exam):
- Use of external nasal dilator strips (e.g., Breathe Right Strips)
- Q-Tip test (manual intranasal lateralization)
- Use of nasal stents
- Cottle Maneuver (manual lateral retraction of the cheek)
Exclusion Criteria:
- Prior surgical treatment of the nasal valve
- Rhinoplasty, septoplasty, inferior turbinate reduction or other surgical nasal procedures within the past three (3) months
- Severe and/or chronic sinusitis, recurrent sinusitis, or allergies leading to nasal obstruction and currently requiring oral corticosteroid therapy
- Severe case of any of the following: septal deviation, turbinate hypertrophy, polyps, or ptotic nose tip believed to be the primary contributor to the subject's nasal obstruction symptoms and warranting surgical intervention
- Known or suspected allergies or contraindications to the anesthetic agents and/or antibiotic medications to be used during the study procedure session
- Known or suspected to be pregnant, or is lactating
- Other medical conditions which in the opinion of the investigator could predispose the subject to poor wound healing or increased surgical risk

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03156270
United States, Ohio | |
The Ohio State Eye and Ear Institute | |
Columbus, Ohio, United States, 43212 |
Principal Investigator: | Brad Otto, MD | The Ohio State Eye and Ear Institute |
Documents provided by Aerin Medical:
Responsible Party: | Aerin Medical |
ClinicalTrials.gov Identifier: | NCT03156270 |
Other Study ID Numbers: |
TP423 |
First Posted: | May 17, 2017 Key Record Dates |
Results First Posted: | June 16, 2021 |
Last Update Posted: | June 16, 2021 |
Last Verified: | October 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
nasal valve nasal airway obstruction |
Airway Obstruction Nasal Obstruction Respiratory Insufficiency Respiration Disorders |
Respiratory Tract Diseases Nose Diseases Otorhinolaryngologic Diseases |